| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |